BSEBoard Meeting5d ago · 28 Aug 2026, 11:02 am

Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve 1. To Fix the Day, Date, Time ....

Genpharmasec Ltd · 531592

✦ AI SummaryResults

Genpharmasec Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 to consider and approve various matters, including fixing the day, date, time, and mode of the 34% Annual General Meeting, and approving the Directors Report and Annual Report for the year ended March 31, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Genpharmasec Ltd - 531592 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, 02Nd September, 2026.

Attachments (1)

📄

810901dd-3983-4468-b933-ec43e3657680.pdf

pdf

Download →
View document text
GENPHARMASEC LIMITED Date: 28.08.2026 BSE Limited The Compliance Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 531592 Subject: Intimation of Board Meeting to be held on Wednesday, 024 September, 2026. Dear Sir/Madam, With reference to the above captioned subject and in accordance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We Would like to inform that the Meeting of Board of Directors of our Company will be held on Wednesday, 025¢ September, 2026 at the Registered Office of the Company, to consider and approve, inter alia other matters, the following: Sr. No. Agenda for the Board Meeting 1. | To Fix the Day, Date, Time and Mode of 34% Annual General Meeting of the Company for the year ended March 31, 2026 and approve Draft notice and Calendar of Events for the same. 2. To Fix the Cut- off date to determine the entitlement of voting rights of members for E-voting and to fix the commencement and closing date for E-voting. To consider and approve the Directors Report for the year ended March 31, 2026. To consider and approve Annual Report for Financial Year 2025-26. To approve closure of Share Transfer Books & Register of Members for the 34t Annual General Meeting. 6. To Consider and approve the appointment of Scrutinizer for E-voting at the ensuing 34% Annual General Meeting. 7. Any other Matter with the permission of the Chairman. Kindly take the same on records for your perusal. Thanking you, For Genpharmasec Limited SOHAN ~ Jeiwamesy @% CHATURVEDI Date: 2026.08.28 ‘X& (3 A, 1052:05 +0530' Mr. Sohan Chaturvedi Whole time director & CFO DIN- 09629728 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc compliance@genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com @ www.genpharmasec.com () +91-86555 50242 CIN : L24231MH1992PLC323914